Form 4: ANI Pharmaceuticals CEO Nikhil Lalwani Sells Shares
SEC Form 4 Filing
ANI Pharmaceuticals' President and CEO, Nikhil Lalwani, sold 16,669 shares of common stock on May 14, 2024.
Summary
- Nikhil Lalwani, President and CEO of ANI Pharmaceuticals, sold 16,669 shares of the company's common stock on May 14, 2024.
- The shares were sold at a weighted average price of $66.1, with individual sales prices ranging from $65.67 to $67.56.
- Following the transaction, Lalwani directly owns 377,505 shares of ANI Pharmaceuticals' common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports a stock sale by an insider, which could be for various personal financial reasons and doesn't necessarily reflect a negative outlook on the company.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings are closely watched by investors for insights into management's perspective on the company's value and future prospects.
Key Dates
| Date | Description |
|---|---|
| 05/14/2024 | Date of stock sale transaction |
| 05/16/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.